Assertio Therapeutics Inc (ASRT)

$0.83 +0.02 (2.83%)
Market Cap 76.81M
Revenue (ttm) 152.07M
Net Income (ttm) -331.94M
EPS (ttm) N/A
PE Ratio 20.65
Forward PE 33.04
Profit Margin -218.28%
Debt to Equity Ratio 0.30
Volume 434,500
Avg Vol 878,810
Day's Range N/A - N/A
Shares Out 95.48M
Stochastic %K 30%
Beta 0.78
Analysts Strong Sell
Price Target $3.03

Latest News on ASRT

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jan 3, 2025, 4:30 PM EST - 14 days ago

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

Dec 17, 2024, 8:30 AM EST - 4 weeks ago

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

Dec 13, 2024, 8:00 AM EST - 5 weeks ago

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio

Nov 15, 2024, 9:00 AM EST - 2 months ago

Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio

Assertio Holdings, Inc. (ASRT) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 6:57 PM EST - 2 months ago

Assertio Holdings, Inc. (ASRT) Q3 2024 Earnings Call Transcript

Assertio Reports Third Quarter 2024 Financial Results

Nov 11, 2024, 4:02 PM EST - 2 months ago

Assertio Reports Third Quarter 2024 Financial Results

Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio

Nov 11, 2024, 3:41 PM EST - 2 months ago

Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio

Assertio Provides Response to Letter from Short-seller

Nov 11, 2024, 7:30 AM EST - 2 months ago

Assertio Provides Response to Letter from Short-seller

Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud

Nov 8, 2024, 9:00 AM EST - 2 months ago

Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

Oct 11, 2024, 8:00 AM EDT - 3 months ago

Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

Assertio Holdings: Management Change Could Improve Comeback Chances

Sep 11, 2024, 4:18 PM EDT - 4 months ago

Assertio Holdings: Management Change Could Improve Comeback Chances

Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024

Sep 3, 2024, 4:05 PM EDT - 4 months ago

Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024

Assertio Holdings, Inc. (ASRT) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 9:45 PM EDT - 5 months ago

Assertio Holdings, Inc. (ASRT) Q2 2024 Earnings Call Transcript

Assertio Reports Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 5 months ago

Assertio Reports Second Quarter 2024 Financial Results

Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 24, 2024, 4:05 PM EDT - 6 months ago

Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024

Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc.

Jul 24, 2024, 9:00 AM EDT - 6 months ago

Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc.

Assertio: An Extremely Asymmetric Bet Skewed To The Upside

Jun 27, 2024, 9:51 AM EDT - 7 months ago

Assertio: An Extremely Asymmetric Bet Skewed To The Upside

Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024

Jun 5, 2024, 8:30 AM EDT - 8 months ago

Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024

Assertio to Participate in Benchmark Healthcare Conference on May 21-22

May 17, 2024, 9:15 AM EDT - 8 months ago

Assertio to Participate in Benchmark Healthcare Conference on May 21-22

BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS

May 17, 2024, 7:30 AM EDT - 8 months ago

BUXTON HELMSLEY RELEASES LETTER FROM CERTIFIED FRAUD EXAMINER ATTESTING TO DISCLOSURE FAILURES AND DEFICIENCIES BY ASSERTIO HOLDINGS BOARD OF DIRECTORS

Assertio to Participate in AGP Healthcare Conference on May 21

May 16, 2024, 9:16 AM EDT - 8 months ago

Assertio to Participate in AGP Healthcare Conference on May 21

BUXTON HELMSLEY URGES ASSERTIO STOCKHOLDERS TO VOTE "AGAINST" DIRECTORS AFTER DISCLOSURE FAILURES, INAPPROPRIATE BOARDROOM ACTIVITY, STRATEGIC BLUNDERS

May 13, 2024, 5:52 PM EDT - 8 months ago

BUXTON HELMSLEY URGES ASSERTIO STOCKHOLDERS TO VOTE "AGAINST" DIRECTORS AFTER DISCLOSURE FAILURES, INAPPROPRIATE BOARDROOM ACTIVITY, STRATEGIC BLUNDERS

Assertio to Present at the Citizens JMP Life Sciences Conference in New York City

May 10, 2024, 3:12 PM EDT - 9 months ago

Assertio to Present at the Citizens JMP Life Sciences Conference in New York City

Assertio Holdings, Inc. (ASRT) Q1 2024 Earnings Call Transcript

May 6, 2024, 7:07 PM EDT - 9 months ago

Assertio Holdings, Inc. (ASRT) Q1 2024 Earnings Call Transcript

Assertio Reports First Quarter 2024 Financial Results

May 6, 2024, 4:01 PM EDT - 9 months ago

Assertio Reports First Quarter 2024 Financial Results

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024

Apr 25, 2024, 8:00 AM EDT - 9 months ago

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024

Assertio to Present at LD Micro Invitational Conference in New York City

Apr 1, 2024, 9:00 AM EDT - 10 months ago

Assertio to Present at LD Micro Invitational Conference in New York City

Assertio Holdings Inc. (ASRT) Q4 2023 Earnings Call Transcript

Mar 11, 2024, 6:02 PM EDT - 11 months ago

Assertio Holdings Inc. (ASRT) Q4 2023 Earnings Call Transcript

Assertio Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 11, 2024, 4:01 PM EDT - 11 months ago

Assertio Reports Fourth Quarter and Full Year 2023 Financial Results

Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

Feb 29, 2024, 4:05 PM EST - 11 months ago

Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Assertio

Feb 29, 2024, 10:45 AM EST - 11 months ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Assertio

Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Investors of March 5, 2024 Lead Plaintiff Deadline and Urges Investors with Substantial Losses to Contact the Firm

Feb 28, 2024, 10:15 AM EST - 11 months ago

Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Investors of March 5, 2024 Lead Plaintiff Deadline and Urges Investors with Substantial Losses to Contact the Firm

ASSERTIO SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options

Feb 16, 2024, 1:15 PM EST - 1 year ago

ASSERTIO SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options

ASSERTIO INVESTOR DEADLINE APPROACHING

Feb 9, 2024, 11:15 AM EST - 1 year ago

ASSERTIO INVESTOR DEADLINE APPROACHING

ASSERTIO INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options

Jan 25, 2024, 11:00 AM EST - 1 year ago

ASSERTIO INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options